Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Matthew Angel currently holds 231,482 shares of Tempest Therapeutics, Inc. (TPST), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Matthew Angel has been a net buyer of TPST stock. They have purchased $500.0K and sold $0 worth of shares.
Matthew Angel's most recent insider trade was on Mar 24, 2026, when they purchased 231,482 shares at $2.16 per share.
Matthew Angel serves as Executive at Tempest Therapeutics, Inc. (TPST). They have executed 1 insider transactions totaling $500.0K over their tenure at the company.
Matthew Angel holds the position of Executive at Tempest Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 1 years and currently hold a stake valued at $0.
Matthew Angel has shown a buying trading pattern, with $500.0K in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Matthew Angel was on Mar 24, 2026, when they purchased $500.0K worth of TPST shares. This transaction involved 231,482 shares at $2.16 per share.
Matthew Angel currently owns 231,482 shares of Tempest Therapeutics, Inc. (TPST), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Matthew Angel's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Matthew Angel has 1 Form 4 filings on record as an insider at Tempest Therapeutics, Inc..
Set alerts for Matthew Angel and 40,000+ other insiders.